You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ebola Disease, Marburg Disease Trial in Atlanta (Ad26 Zaire Ebola Vaccine, MVA Multi-Filo Ebola Vaccine)

Completed
  • Ebola Disease
  • Marburg Disease
  • Ad26 Zaire Ebola Vaccine
  • MVA Multi-Filo Ebola Vaccine
  • Atlanta, Georgia
    Emory Children's Center - Pediatric Infectious Diseases
Feb 18, 2021

After Immunisation With Ebola Virus Vaccines

Completed
  • Ebola Virus Disease
  • Previously exposed to Ebola vaccine
  • Glasgow, United Kingdom
  • +1 more
Jul 14, 2020

Respiratory Syncytial Viruses, Lower Respiratory Tract Disease Trial in Worldwide (Adenovirus serotype 26 (Ad26)-based

Recruiting
  • Respiratory Syncytial Viruses
  • Lower Respiratory Tract Disease
  • Adenovirus serotype 26 (Ad26)-based respiratory syncytial virus (RSV). preF
  • Placebo
  • Birmingham, Alabama
  • +341 more
Aug 2, 2022

Healthy Trial in Mount Pleasant (Ad26.RSV.preF, Fluarix, Placebo)

Completed
Has Results
  • Healthy
  • Ad26.RSV.preF
  • +2 more
  • Mount Pleasant, South Carolina
    Coastal Carolina Research Center
Jul 22, 2021

Healthy Trial in United States (RSV Vaccine, Placebo)

Completed
  • Healthy
  • RSV Vaccine
  • Placebo
  • San Diego, California
  • +8 more
Sep 23, 2021

Angina, Stable Trial (Ad5FGF-4, Placebo)

Not yet recruiting
  • Angina, Stable
  • Ad5FGF-4
  • Placebo
  • (no location specified)
Jul 18, 2022

Respiratory Syncytial Virus Prevention Trial in United States (Ad26.RSV.PreF-based Vaccine)

Completed
  • Respiratory Syncytial Virus Prevention
  • Ad26.RSV.PreF-based Vaccine
  • Athens, Alabama
  • +12 more
Oct 25, 2022

Respiratory Syncytial Virus Infection Prevention Trial in Worldwide (Ad26.RSV.preF-based Vaccine, Placebo)

Completed
  • Respiratory Syncytial Virus Infection Prevention
  • Ad26.RSV.preF-based Vaccine
  • Placebo
  • Coral Gables, Florida
  • +22 more
Sep 27, 2022

SARS CoV 2 Infection Trial in South Africa (Booster vaccine)

Recruiting
  • SARS CoV 2 Infection
  • Booster vaccine
  • Mthatha, Eastern Cape, South Africa
  • +30 more
Jul 29, 2022

Healthy Trial in Worldwide (Ad26.COV2.S, Placebo)

Completed
  • Healthy
  • Ad26.COV2.S
  • Placebo
  • Berlin, Germany
  • +12 more
May 3, 2022

Ebola Virus Disease Trial in Kenema (rVSVDG-ZEBOV-GP Ebola Virus Vaccine (ERVEBO))

Not yet recruiting
  • Ebola Virus Disease
  • rVSVDG-ZEBOV-GP Ebola Virus Vaccine (ERVEBO)
  • Kenema, Eastern, Sierra Leone
    Kenema Government Hospital
Aug 7, 2023

HIV-1 Trial in Worldwide (Ad26.Mos4.HIV, Clade C gp140, Placebo)

Completed
  • HIV-1
  • Ad26.Mos4.HIV
  • +2 more
  • Lilongwe, Malawi
  • +22 more
Apr 12, 2022

Respiratory Syncytial Virus Prevention Trial in Japan (Ad26/protein preF RSV Vaccine, Placebo)

Recruiting
  • Respiratory Syncytial Virus Prevention
  • Ad26/protein preF RSV Vaccine
  • Placebo
  • Akashi-shi, Japan
  • +29 more
Aug 2, 2022

HIV, AIDS, Immunologic Deficiency Syndrome, Acquired Trial in Boston (Ad26.Mos4.HIV, MVA-BN-HIV, PGT121)

Recruiting
  • HIV
  • +4 more
  • Ad26.Mos4.HIV
  • +4 more
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Apr 18, 2022

HIV Trial in United States (MRKAd5 HIV-1 gag/pol/nef)

Completed
  • HIV Infections
  • MRKAd5 HIV-1 gag/pol/nef
  • Birmingham, Alabama
  • +3 more
Oct 13, 2021

Influenza, Human Prevention, Respiratory Syncytial Viruses Prevention Trial in United States (Ad26.RSV.preF-based vaccine,

Completed
  • Influenza, Human Prevention
  • Respiratory Syncytial Viruses Prevention
  • Ad26.RSV.preF-based vaccine
  • +2 more
  • Long Beach, California
  • +18 more
Oct 25, 2022

Coronavirus Disease-2019 (COVID-19) Prevention Trial in Worldwide (Ad26.COV2.S)

Active, not recruiting
  • Coronavirus Disease-2019 (COVID-19) Prevention
  • Ad26.COV2.S
  • Buenos Aires, Argentina
  • +17 more
Jan 17, 2023

Healthy Volunteers Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (rVSV-Zebov GP vaccine)

Active, not recruiting
  • Healthy Volunteers
  • rVSV-Zebov GP vaccine
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 7, 2023

Vaccine-induced Immunity Against Ebola in Previously Vaccinated

Recruiting
  • Immune Response
    • Goma, Congo, The Democratic Republic of the
    • +1 more
    May 18, 2022

    SARS (Severe Acute Respiratory Syndrome) Trial in South Africa (To monitor the effectiveness of the single dose Ad26.COV2.S

    Completed
    • SARS (Severe Acute Respiratory Syndrome)
    • To monitor the effectiveness of the single dose Ad26.COV2.S COVID-19 vaccine
    • Mthatha, Eastern Cape, South Africa
    • +30 more
    Jul 29, 2022

    X-Linked Retinitis Pigmentosa Trial in Meguro-ku (AAV5-hRKp.RPGR)

    Not yet recruiting
    • X-Linked Retinitis Pigmentosa
    • AAV5-hRKp.RPGR
    • Meguro-ku, Japan
      National Hospital Organization Tokyo Medical Center
    Jun 23, 2023

    Danon Disease Trial in La Jolla, Philadelphia (RP-A501)

    Recruiting
    • Danon Disease
    • RP-A501
    • La Jolla, California
    • +1 more
    Oct 17, 2023

    COVID-19 Prevention Trial in Worldwide (Ad26.COV2.S)

    Recruiting
    • COVID-19 Prevention
    • Ad26.COV2.S
    • Birmingham, Alabama
    • +48 more
    Aug 2, 2022

    COVID-19 Prevention Trial in Worldwide (Ad26.COV2.S)

    Recruiting
    • COVID-19 Prevention
    • Ad26.COV2.S
    • Little Rock, Arkansas
    • +54 more
    Aug 2, 2022

    Pancreatic Adenocarcinoma, Ovarian Cancer, Biliary Carcinoma Trial in Stockholm, Uppsala (LOAd703)

    Recruiting
    • Pancreatic Adenocarcinoma
    • +3 more
    • Stockholm, Sweden
    • +1 more
    Apr 4, 2022